FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002187079> ?p ?o ?g. }

• W2002187079 endingPage "889" @default.
• W2002187079 startingPage "883" @default.
• W2002187079 abstract "Background GW320659, a highly selective neuronal norepinephrine and dopamine re-uptake inhibitor, has been evaluated for the treatment of obesity. Scrutiny of the weight loss data from a phase II study (GlaxoSmithKline study OBS20001) showed a wide variation in weight loss response following GW320659 treatment and the possibility that the study population might include subgroups with enhanced weight loss response. Methods Pharmacogenetic analysis was performed in 191 subjects prospectively ascertained from a Phase II dose ranging study to evaluate the influence of genotype on weight loss efficacy and safety of GW320659 in obese subjects. Results Common genetic polymorphisms in the drug target (norepinephrine transporter protein 1, SLC6A2) and mechanism pathway (NMDA receptor channel NR1 subunit, GRIN1) were associated with increased weight loss following GW320659 treatment in a proportion (36%) of the study population. In the patient subgroup selected for these genotypes, GW320659 (15 mg/day) produced a significant difference in mean weight loss of 7.84 kg (SD 5.23, n=14), compared to 2.53 kg (SD 5.17, n=24) in the subgroup that did not possess the genotypes (P=0.006). This subgroup also showed a highly significant weight loss response for GW320659 compared to placebo (+0.31 kg, SD 3.32, n=16) with the same genotypes (P<0.0001). In addition, there was no difference in placebo response between either subgroup. Conclusions Polymorphisms in SLC6A2 and GRIN1 could be used to maximize effective obesity pharmacotherapy by norepinephrine/dopamine transporter inhibitors by identifying patients that may be predisposed to particularly good treatment weight loss response." @default.
• W2002187079 created "2016-06-24" @default.
• W2002187079 creator A5059069906 @default.
• W2002187079 creator A5059178363 @default.
• W2002187079 creator A5066067972 @default.
• W2002187079 creator A5076852373 @default.
• W2002187079 creator A5078361174 @default.
• W2002187079 creator A5090335322 @default.
• W2002187079 creator A5090569050 @default.
• W2002187079 creator A5090837580 @default.
• W2002187079 date "2005-12-01" @default.
• W2002187079 modified "2023-10-18" @default.
• W2002187079 title "Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects" @default.
• W2002187079 cites W1506043277 @default.
• W2002187079 cites W1544939802 @default.
• W2002187079 cites W1604789859 @default.
• W2002187079 cites W171174430 @default.
• W2002187079 cites W1972804778 @default.
• W2002187079 cites W1980247209 @default.
• W2002187079 cites W2012508821 @default.
• W2002187079 cites W2022902540 @default.
• W2002187079 cites W2023220345 @default.
• W2002187079 cites W2030676726 @default.
• W2002187079 cites W2050301854 @default.
• W2002187079 cites W2053185529 @default.
• W2002187079 cites W2058783998 @default.
• W2002187079 cites W2065517231 @default.
• W2002187079 cites W2072069204 @default.
• W2002187079 cites W2073850633 @default.
• W2002187079 cites W2082335023 @default.
• W2002187079 cites W2092868760 @default.
• W2002187079 cites W2099249910 @default.
• W2002187079 cites W2133090145 @default.
• W2002187079 cites W2133465432 @default.
• W2002187079 cites W2151048121 @default.
• W2002187079 cites W2159075930 @default.
• W2002187079 cites W2168978361 @default.
• W2002187079 cites W2339428433 @default.
• W2002187079 doi "https://doi.org/10.1097/01213011-200512000-00006" @default.
• W2002187079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16272960" @default.
• W2002187079 hasPublicationYear "2005" @default.
• W2002187079 type Work @default.
• W2002187079 sameAs 2002187079 @default.
• W2002187079 citedByCount "15" @default.
• W2002187079 countsByYear W20021870792015 @default.
• W2002187079 countsByYear W20021870792018 @default.
• W2002187079 countsByYear W20021870792022 @default.
• W2002187079 countsByYear W20021870792023 @default.
• W2002187079 crossrefType "journal-article" @default.
• W2002187079 hasAuthorship W2002187079A5059069906 @default.
• W2002187079 hasAuthorship W2002187079A5059178363 @default.
• W2002187079 hasAuthorship W2002187079A5066067972 @default.
• W2002187079 hasAuthorship W2002187079A5076852373 @default.
• W2002187079 hasAuthorship W2002187079A5078361174 @default.
• W2002187079 hasAuthorship W2002187079A5090335322 @default.
• W2002187079 hasAuthorship W2002187079A5090569050 @default.
• W2002187079 hasAuthorship W2002187079A5090837580 @default.
• W2002187079 hasConcept C104317684 @default.
• W2002187079 hasConcept C126322002 @default.
• W2002187079 hasConcept C134018914 @default.
• W2002187079 hasConcept C135763542 @default.
• W2002187079 hasConcept C137183658 @default.
• W2002187079 hasConcept C142724271 @default.
• W2002187079 hasConcept C176233148 @default.
• W2002187079 hasConcept C204787440 @default.
• W2002187079 hasConcept C27081682 @default.
• W2002187079 hasConcept C2776755682 @default.
• W2002187079 hasConcept C2778514916 @default.
• W2002187079 hasConcept C2908647359 @default.
• W2002187079 hasConcept C511355011 @default.
• W2002187079 hasConcept C513476851 @default.
• W2002187079 hasConcept C54355233 @default.
• W2002187079 hasConcept C544821477 @default.
• W2002187079 hasConcept C55775858 @default.
• W2002187079 hasConcept C71924100 @default.
• W2002187079 hasConcept C86803240 @default.
• W2002187079 hasConcept C98274493 @default.
• W2002187079 hasConcept C99454951 @default.
• W2002187079 hasConceptScore W2002187079C104317684 @default.
• W2002187079 hasConceptScore W2002187079C126322002 @default.
• W2002187079 hasConceptScore W2002187079C134018914 @default.
• W2002187079 hasConceptScore W2002187079C135763542 @default.
• W2002187079 hasConceptScore W2002187079C137183658 @default.
• W2002187079 hasConceptScore W2002187079C142724271 @default.
• W2002187079 hasConceptScore W2002187079C176233148 @default.
• W2002187079 hasConceptScore W2002187079C204787440 @default.
• W2002187079 hasConceptScore W2002187079C27081682 @default.
• W2002187079 hasConceptScore W2002187079C2776755682 @default.
• W2002187079 hasConceptScore W2002187079C2778514916 @default.
• W2002187079 hasConceptScore W2002187079C2908647359 @default.
• W2002187079 hasConceptScore W2002187079C511355011 @default.
• W2002187079 hasConceptScore W2002187079C513476851 @default.
• W2002187079 hasConceptScore W2002187079C54355233 @default.
• W2002187079 hasConceptScore W2002187079C544821477 @default.
• W2002187079 hasConceptScore W2002187079C55775858 @default.
• W2002187079 hasConceptScore W2002187079C71924100 @default.
• W2002187079 hasConceptScore W2002187079C86803240 @default.
• W2002187079 hasConceptScore W2002187079C98274493 @default.

• next